The impact of azithromycin therapy on the airway microbiota in asthma

Slater, Mariel and Rivett, Damian W. and Williams, Lisa and Martin, Matthew and Harrison, Timothy W. and Sayers, Ian and Bruce, Kenneth D. and Shaw, Dominick E. (2014) The impact of azithromycin therapy on the airway microbiota in asthma. Thorax, 69 (7). pp. 673-674. ISSN 1468-3296

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Available under Licence Creative Commons Attribution Non-commercial.
Download (404kB) | Preview
[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (274kB) | Preview

Abstract

There is interest in the use of macrolide antibiotics in asthma. Macrolides have been shown to improve airway hyperresponsiveness (AHR) and measures of airway inflammation.The degree of AHR may relate to the microbiota present in the airways, with a recent study reporting that patients with asthma with a significant improvement in AHR following treatment with clarithromycin had a higher bacterial diversity prior to treatment. To our knowledge, the impact on the asthmatic airway microbiota of an antibiotic has not been reported and we therefore set out to establish if macrolide therapy was associated with a change in airway microbiota in asthma.

Item Type: Article
Schools/Departments: University of Nottingham, UK > Faculty of Medicine and Health Sciences > School of Medicine > Division of Respiratory Medicine
Identification Number: https://doi.org/10.1136/thoraxjnl-2013-204517
Depositing User: Eprints, Support
Date Deposited: 05 Apr 2016 12:57
Last Modified: 08 Dec 2016 02:36
URI: http://eprints.nottingham.ac.uk/id/eprint/32641

Actions (Archive Staff Only)

Edit View Edit View